PRPH - ProPhase Labs Inc

https://www.prophaselabs.com

Momentum: Bearish

Recent News

Bullish

ProPhase Labs Stockholders Approve All Proposals at September 9, 2025 Special Meeting By More Than 75% In Favor

GlobeNewswire • 3 days, 3 hours ago • score: 0.55

ProPhase Labs Stockholders Deliver Strong Mandate at Special Meeting ...

Bullish

ProPhase Labs Announces Special Meeting of Shareholders and Filing of Preliminary Proxy Statement

GlobeNewswire • 1 month, 2 weeks ago • score: 0.53

Proxy Sets Company on a Path to Attract the Optimal Crypto Treasury Strategy ...

Interval:

EMA1: EMA2:

AI Tools

Key Metrics

Trend: Downtrend

Source: Snapshot

ProPhase Labs, Inc. is engaged in the research, development, manufacture, distribution, marketing, and sale of consumer health products and over-the-counter (OTC) dietary supplements in the United States. The company is headquartered in Garden City, New York.

52W High

$2.97

52W Low

$0.22

MA Status:

50D: Below 200D: Below

Beta (~1 neutral, <0.9 lower risk)

-0.77

Valuation

Attractive

As of 2025-06-30 (Overview)

Trailing P/E (<15 better)

N/A

Forward P/E (<15 better)

10.09

EV/EBITDA (<8 favorable)

2.45

EV/Revenue (<3 favorable)

4.02

P/S (TTM) (<3 favorable)

2.64

P/B (<3 favorable)

1.29

Ownership

Retail‑heavy

Source: Overview

Insiders (1–5% typical)

7.99%

Institutions (25–75% balanced)

6.57%

Shares Outstanding

41,541,200

Float

38,222,100

Dividend Yield (2–6% sweet spot)

N/A

Ex‑Dividend Date

2022-05-24

Income & Growth

Profitability: Weak

As of 2025-06-30 (Overview)

Revenue (TTM)

5,588,000

Gross Profit (TTM)

1,325,000

EPS (TTM)

-2.07

Profit Margin (>10% good)

N/A

Operating Margin (TTM) (higher better)

-3.12%

ROE (TTM) (>15% strong)

-1.72%

EPS YoY (Quarterly) (>10% good)

-0.95

Revenue YoY (Quarterly) (>8% good)

-0.17

Momentum

Bearish momentum

Value

0.0392

0.0410

Trend

Falling

Signal Cross

No cross

As of

Sep. 12, 2025